ARCHIVES

Vaccine Increases PFS 146%, OS 60% In Phase II Clinical Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Basic Research Group Seeks $7.9 Billion For NIH, $1.7 For NCI

July 24, 1987

Prevention Clinical Trials Heads Greenwalk Priority Lists For ‘86

February 8, 1985

In Brief: Howley, Simone Lead Cancer Policy Board: AMA Campaign Fights Youth Smoking

November 22, 1996

Zevalin Regimen Effective In Mantle Cell Lymphoma

January 30, 2004

Schering to Pay $435M to Settle Federal Charges.

January 26, 2007

“With resources now constrained, the ability of NCI to be responsive to its constituencies has been compromised.”

July 7, 1995